Diane Stephenson

7.4k total citations
115 papers, 4.2k citations indexed

About

Diane Stephenson is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Diane Stephenson has authored 115 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 32 papers in Cellular and Molecular Neuroscience and 30 papers in Physiology. Recurrent topics in Diane Stephenson's work include Parkinson's Disease Mechanisms and Treatments (26 papers), Alzheimer's disease research and treatments (21 papers) and Health Systems, Economic Evaluations, Quality of Life (19 papers). Diane Stephenson is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (26 papers), Alzheimer's disease research and treatments (21 papers) and Health Systems, Economic Evaluations, Quality of Life (19 papers). Diane Stephenson collaborates with scholars based in United States, United Kingdom and Belgium. Diane Stephenson's co-authors include James A. Clemens, Sheila P. Little, E. Barry Smalstig, Daniel Morton, Karen Rash, Eric P. Dixon, Frank S. Menniti, Robin J. Kleiman, Wendy O. Adamowicz and P. D. Kushner and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Diane Stephenson

107 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diane Stephenson United States 34 1.9k 1.0k 843 731 622 115 4.2k
Na Zhao China 31 1.8k 0.9× 1.8k 1.8× 612 0.7× 943 1.3× 385 0.6× 139 4.9k
Mitchell K.P. Lai Singapore 40 1.4k 0.7× 1.6k 1.5× 701 0.8× 1.0k 1.4× 505 0.8× 144 4.8k
Kathleen S. Montine United States 41 2.7k 1.4× 1.9k 1.8× 746 0.9× 1.0k 1.4× 481 0.8× 114 5.7k
Mikko Hiltunen Finland 40 2.5k 1.3× 2.6k 2.4× 975 1.2× 936 1.3× 496 0.8× 157 5.9k
Robert Nisticò Italy 43 1.8k 1.0× 1.3k 1.2× 1.7k 2.0× 976 1.3× 450 0.7× 149 4.9k
Seong‐Ho Koh South Korea 36 2.1k 1.1× 1.3k 1.2× 793 0.9× 1.5k 2.1× 503 0.8× 166 5.5k
Elena Alberdi Spain 38 1.6k 0.8× 1.0k 1.0× 1.4k 1.7× 1.3k 1.8× 353 0.6× 71 4.6k
Andrew A. Pieper United States 44 2.8k 1.5× 934 0.9× 839 1.0× 577 0.8× 317 0.5× 128 5.9k
Bin Cheng United States 32 1.8k 0.9× 2.3k 2.2× 1.6k 1.9× 568 0.8× 697 1.1× 126 6.0k
Zsuzsanna Nagy United Kingdom 38 1.3k 0.7× 1.6k 1.5× 537 0.6× 466 0.6× 322 0.5× 90 3.8k

Countries citing papers authored by Diane Stephenson

Since Specialization
Citations

This map shows the geographic impact of Diane Stephenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane Stephenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane Stephenson more than expected).

Fields of papers citing papers by Diane Stephenson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diane Stephenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane Stephenson. The network helps show where Diane Stephenson may publish in the future.

Co-authorship network of co-authors of Diane Stephenson

This figure shows the co-authorship network connecting the top 25 collaborators of Diane Stephenson. A scholar is included among the top collaborators of Diane Stephenson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diane Stephenson. Diane Stephenson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mammen, Jennifer R., Aaron B. Lerner, Melissa Kostrzebski, et al.. (2025). Longitudinal qualitative assessment of meaningful symptoms and relevance of WATCH-PD digital measures for people with early Parkinson’s. Journal of Neurology. 272(2). 114–114. 4 indexed citations
2.
3.
Coon, Cheryl D., Hien Q. Huynh, Diane Stephenson, et al.. (2025). Advancing the Integration of Digital Health Technologies in the Drug Development Ecosystem. Journal of Medical Internet Research. 27. e67052–e67052.
4.
Mammen, Jennifer R., et al.. (2024). Understanding what aspects of Parkinson’s disease matter most to patients and families. Scientific Reports. 14(1). 21171–21171. 6 indexed citations
5.
Kopil, Catherine, Sohini Chowdhury, David T. Dexter, et al.. (2024). A Coalition to Advance Treatments for Parkinson’s Disease, Dementia with Lewy Bodies, and Related Disorders. Journal of Parkinson s Disease. 14(6). 1105–1114. 2 indexed citations
6.
Mestre, Tiago, Glenn T. Stebbins, Diane Stephenson, et al.. (2024). Patient-centered development of clinical outcome assessments in early Parkinson disease: key priorities and advances. npj Parkinson s Disease. 10(1). 101–101. 4 indexed citations
7.
Stephenson, Diane, et al.. (2023). Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop. Neurotherapeutics. 20(6). 1682–1691. 13 indexed citations
8.
Izmailova, Elena S., et al.. (2023). Digital technologies: Innovations that transform the face of drug development. Clinical and Translational Science. 16(8). 1323–1330. 9 indexed citations
9.
Roussos, George, David Hill, Ariel V. Dowling, et al.. (2022). Identifying and characterising sources of variability in digital outcome measures in Parkinson’s disease. npj Digital Medicine. 5(1). 93–93. 15 indexed citations
10.
Stephenson, Diane, et al.. (2021). Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective. Journal of Parkinson s Disease. 11(s1). S103–S109. 33 indexed citations
11.
Kruizinga, Matthijs D., Frederik E. Stuurman, Vasileios Exadaktylos, et al.. (2020). Development of Novel, Value-Based, Digital Endpoints for Clinical Trials: A Structured Approach Toward Fit-for-Purpose Validation. Pharmacological Reviews. 72(4). 899–909. 34 indexed citations
12.
Ropacki, Michael T., Kristín Hannesdóttir, Suzanne Hendrix, et al.. (2017). Clinically Meaningful Outcomes in Early Alzheimer Disease: A Consortia-Driven Approach to Identifying What Matters to Patients. Therapeutic Innovation & Regulatory Science. 51(3). 380–390. 6 indexed citations
13.
Stephenson, Diane, Sharon O'Neill, Aadhya Tiwari, et al.. (2011). Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis. Molecular Autism. 2(1). 7–7. 145 indexed citations
14.
Stephenson, Diane, et al.. (2005). The Effects of a Selective Dopamine D2 Receptor Agonist on Behavioral and Pathological Outcome in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Treated Squirrel Monkeys. Journal of Pharmacology and Experimental Therapeutics. 314(3). 1257–1266. 19 indexed citations
15.
16.
Gehlert, Donald R., Diane Stephenson, Douglas A. Schober, Karen Rash, & James A. Clemens. (1997). Increased expression of peripheral benzodiazepine receptors in the facial nucleus following motor neuron axotomy. Neurochemistry International. 31(5). 705–713. 33 indexed citations
17.
Stephenson, Diane, Joseph Manetta, D. L. White, et al.. (1994). Calcium-sensitive cytosolic phospholipase A2 (cPLA2) is expressed in human brain astrocytes. Brain Research. 637(1-2). 97–105. 76 indexed citations
18.
Clemens, James A. & Diane Stephenson. (1992). Implants containing β-amyloid protein are not neurotoxic to young and old rat brain. Neurobiology of Aging. 13(5). 581–586. 64 indexed citations
19.
Podlisny, Marcia B., Diane Stephenson, Matthew P. Frosch, et al.. (1992). Synthetic amyloid β-protein fails to produce specific neurotoxicity in monkey cerebral cortex. Neurobiology of Aging. 13(5). 561–567. 52 indexed citations
20.
Wright, Stephen E., et al.. (1990). Family of human neuronal external surface epitopes defined by torpedo monoclonal antibodies. Journal of Neuroscience Research. 25(4). 486–502. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Na Zhao Breakdown of academic impact, for papers by Mitchell K.P. Lai Breakdown of academic impact, for papers by Kathleen S. Montine Breakdown of academic impact, for papers by Mikko Hiltunen Breakdown of academic impact, for papers by Robert Nisticò Breakdown of academic impact, for papers by Seong‐Ho Koh Breakdown of academic impact, for papers by Elena Alberdi Breakdown of academic impact, for papers by Andrew A. Pieper Breakdown of academic impact, for papers by Bin Cheng Breakdown of academic impact, for papers by Zsuzsanna Nagy
Rankless by CCL
2026